A century of dissolution research: From Noyes and Whitney to the Biopharmaceutics Classification System
about
Derivation of occupational exposure levels (OELs) of low-toxicity isometric biopersistent particles: How can the kinetic lung overload paradigm be used for improved inhalation toxicity study design and OEL-derivation?Accelerated dissolution testing for controlled release microspheres using the flow-through dissolution apparatus.Understanding peroral absorption: regulatory aspects and contemporary approaches to tackling solubility and permeability hurdlesExperimental and mathematical studies on the drug release properties of aspirin loaded chitosan nanoparticles.Supersaturated dissolution data and their interpretation: the TPGS-carbamazepine model case.The differences between the branded and generic medicines using solid dosage forms: In-vitro dissolution testing.Development and validation of a discriminative dissolution test for betamethasone sodium phosphate and betamethasone dipropionate intramuscular injectable suspension.The role of mass balance equations in growth mechanics illustrated in surface and volume dissolutionsEngineering cells with intracellular agent-loaded microparticles to control cell phenotype.Smart Nanoparticles for Drug Delivery: Boundaries and OpportunitiesA Kinetics and Equilibrium Study of Vanadium Dissolution from Vanadium Oxides and Phosphates in Battery Electrolytes: Possible Impacts on ICD Battery Performance.Hydroxypropyl-β-cyclodextrin functionalized calcium carbonate microparticles as a potential carrier for enhancing oral delivery of water-insoluble drugs.Modeling transportation of efavirenz: inference on possibility of mixed modes of transportation and kinetic solubility.Challenges and opportunities in achieving bioequivalence for fixed-dose combination products.Accelerated in-vitro release testing methods for extended-release parenteral dosage forms.Micronized Organic Magnesium Salts Enhance Opioid Analgesia in Rats.Effect of particle size on solubility, dissolution rate, and oral bioavailability: evaluation using coenzyme Q₁₀ as naked nanocrystals.In vitro models for processes involved in intestinal absorption.In Vitro Dissolution Testing Strategies for Nanoparticulate Drug Delivery Systems: Recent Developments and Challenges.A Review of Disintegration Mechanisms and Measurement Techniques.A perspective on synthetic and solid-form enablement of inhalation candidates.Overcoming sink limitations in dissolution testing: a review of traditional methods and the potential utility of biphasic systems.Inorganic matrices: an answer to low drug solubility problem.Microenvironmental pH-modification to improve dissolution behavior and oral absorption for drugs with pH-dependent solubility.Smart drug delivery systems: from fundamentals to the clinic.Analytical technologies for real-time drug dissolution and precipitation testing on a small scale.Amorphous solid dispersions: a robust platform to address bioavailability challenges.Structural and silver/vanadium ratio effects on silver vanadium phosphorous oxide solution formation kinetics: impact on battery electrochemistry.The Precipitation Behavior of Poorly Water-Soluble Drugs with an Emphasis on the Digestion of Lipid Based Formulations.Application of UV Imaging in Formulation Development.Computational-Regulatory Developments in the Prediction of Oral Drug Absorption.Lipid-associated oral delivery: Mechanisms and analysis of oral absorption enhancement.Silver vanadium oxide and silver vanadium phosphorous oxide dissolution kinetics: a mechanistic study with possible impact on future ICD battery lifetimes.Synthesis and evaluation of mesoporous carbon/lipid bilayer nanocomposites for improved oral delivery of the poorly water-soluble drug, nimodipine.Development of a continuous dissolution/absorption system--a technical note.Dissolution rate enhancement of clarithromycin using ternary ground mixtures: nanocrystal formationAssessing the In Vitro Drug Release from Lipid-Core Nanocapsules: a New Strategy Combining Dialysis Sac and a Continuous-Flow System.Multiple Functions of D-α-Tocopherol Polyethylene Glycol 1000 Succinate (TPGS) as Curcumin Nanoparticle Stabilizer: In Vivo Kinetic Profile and Anti-Ulcerative Colitis Analysis in Animal Model.Pharmacokinetic evaluation of intranasally administered vinyl polymer-coated lorazepam microparticles in rabbits.Real-time dissolution behavior of furosemide in biorelevant media as determined by UV imaging.
P2860
Q28387611-5D306B93-DEF5-4D97-AD42-E75664594223Q33368687-050EDA82-AC3B-4EA8-B7D4-82A37DA2FEF3Q33683206-90577B2C-0311-4617-9403-8CEF2E812EA0Q33760050-34813DAC-931A-44D2-9956-F9E9E84E75B7Q33958686-424A8721-7388-4E84-918A-23FBC8A40641Q34203174-65F7E464-A136-46E9-BE29-9E975FE12BB7Q34570631-AC227903-8182-4A59-8C79-9BA9D61C0338Q34915710-10149B5F-8CCC-4C20-AD26-43282E21009DQ35060703-FB4D62CF-C2D3-4250-8AA1-246A8E95CE90Q35067230-A0048188-89DB-4679-8222-637A5B44D698Q35317349-4CC003A2-BDFA-49FB-9790-FF820F69140BQ35586493-1EFAC740-283F-4B27-9298-117ADBEA1991Q35691622-E6C568C1-3053-4D5E-A63B-D15550D35269Q36065586-76B79ECC-23FF-454A-8151-6F556E4736CCQ36129913-E37E400A-011F-4FCB-804C-079207C12C16Q36177137-5AAA92EC-6F6F-4860-A6A4-9914C3AE9862Q36404933-EABDDF9C-69DB-402D-BC70-79B986DB78CAQ36909324-7EB6DBE5-CD6C-4FC8-8AE3-5489068E3348Q37189129-9871C4D3-8540-45C8-A774-E1E3598646B5Q37739106-FE21CC74-7227-418B-A346-1B2431E526C4Q37937560-1744210F-CE4A-49BE-868E-D2E99331FBFCQ38051448-4CCFD9B1-1B20-4139-BA8A-4C9CF16D08F3Q38051672-103E6A38-B1B9-4B46-8781-C7018E43F07BQ38182718-D57F491C-5847-402B-9D0A-93B2AA807528Q38210020-EDED959A-73E5-4E5F-8E52-493CE05CFEA5Q38212289-78252A48-8A97-4981-8350-08DB79FBC92BQ38358879-B432BA90-F27E-4D2F-ACA0-E84924A4E75BQ38417449-8B392276-7143-4388-859D-2C51C4A2A875Q38644728-9B3AEE0F-F88F-4903-82EE-7B800F2BBD71Q38808298-F8EB5243-C1CC-429D-BD91-2142D63838FFQ38910818-72075B8E-2EB3-4855-BC4C-8BBA3C96C34BQ38926514-C18819D7-0F13-41FA-8BC2-1EDF7D078DA9Q39370593-0D0FFE93-0DA6-4870-9776-F4F23FB8791CQ41547567-2359DD9D-9247-4158-8E52-A7073601A689Q41854431-8457BC9E-B035-4EF0-99D8-C63287F1C61FQ41945650-B562C906-F0C5-427F-BE87-96CAA015DC63Q41987489-70889E40-7403-4E9F-9607-DC0E1DB9AC95Q42366826-4F2CDAE1-4CF5-44E4-8522-A46634A330EBQ42546761-41BEC847-4B27-48A9-95B2-C8C750C7B30EQ44305329-EA444612-A495-487A-81E9-71624D5E2296
P2860
A century of dissolution research: From Noyes and Whitney to the Biopharmaceutics Classification System
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
A century of dissolution resea ...... aceutics Classification System
@ast
A century of dissolution resea ...... aceutics Classification System
@en
type
label
A century of dissolution resea ...... aceutics Classification System
@ast
A century of dissolution resea ...... aceutics Classification System
@en
prefLabel
A century of dissolution resea ...... aceutics Classification System
@ast
A century of dissolution resea ...... aceutics Classification System
@en
P3181
P1476
A century of dissolution resea ...... aceutics Classification System
@en
P2093
Panos Macheras
P3181
P356
10.1016/J.IJPHARM.2006.07.011
P407
P577
2006-09-01T00:00:00Z